Yusuke Hirata
Sendai, 9808578, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
AMPK Limits MNNG-Induced Parthanatos by Inhibiting BH3-Only Protein Bim.
Journal: International journal of molecular sciences
Published: September 19, 2025
Cephalothin, a First-Generation Cephem Antibiotic, Works as a Potent Inducer of Parthanatos.
Journal: Biological & pharmaceutical bulletin
Published: September 10, 2025
Tocotrienols exhibit superior ferroptosis inhibition over tocopherols.
Journal: Scientific reports
Published: August 04, 2025
The degree of caspase-3 aggregation determines the selectivity of arsenic-induced cell death.
Journal: The Journal of toxicological sciences
Published: July 02, 2025
FBXO22 Suppresses Oxidative Stress-Induced ASK1 Activation and Cell Death via Ubiquitination-Dependent Degradation of TRIM48.
Journal: International journal of molecular sciences
Published: June 12, 2025
The antirheumatic drug sulfasalazine ameliorates acute renal failure (ARF) induced by polymyxin B.
Journal: The Journal of antibiotics
Published: February 07, 2025
Truncated LKB1 nonenzymatically enhances Fas-induced apoptosis by acting as a surrogate of Smac.
Journal: Cell death discovery
Published: January 15, 2025
Benzalkonium chloride initiates proinflammatory responses via NLRP3 inflammasome activation.
Journal: The Journal of toxicological sciences
Published: January 08, 2025
The Selective 3-MST Inhibitor I3MT-3 Works as a Potent Caspase-1 Inhibitor.
Journal: International journal of molecular sciences
Published: January 07, 2025
Elaidic acid drives cellular senescence and inflammation via lipid raft-mediated IL-1R signaling.
Journal: iScience
Published: December 09, 2024
Generation of thiyl radicals in a spatiotemporal controlled manner by light: Applied for the cis to trans isomerization of unsaturated fatty acids/phospholipids.
Journal: Redox biology
Published: November 12, 2024
A Novel Oncolytic Viral Therapy Using Coxsackievirus B3 (CVB3) for Human Pancreatic Cancer Including Cancer-associated Fibroblasts.
Journal: Anticancer research
Published: August 25, 2024
Last Updated: 09/26/2026